PDK1 and cancer: K-ras, CDKN2A, p53, DPC4 and 3-phosphoinositide-dependent protein kinase-1 (PDK1) are known to be mutated or inactivated during PC tumorigenesis, and mediate other functional and relevant cancer pathways (4–7).